NCT06331494View on ClinicalTrials.gov

Efficacy of Butylphthalide on Symptomatic Atherosclerotic Stenosis in Middle Cerebral Artery

NANot yet recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

August 31, 2026

Conditions
Ischemic Stroke, AcuteIntracranial Atherosclerosis
Interventions
DRUG

Butylphthalide

Butylphthalide Sodium Chloride injection for 10±3 days, oral Butylphthalide soft capsules for day 11±3 to day 180.

DRUG

Placebo

Butylphthalide Placebo injection for 10±3 days, oral Butylphthalide Placebo soft capsules for day 11±3 to day 180.

Trial Locations (1)

510080

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

First Affiliated Hospital, Sun Yat-Sen University

OTHER

NCT06331494 - Efficacy of Butylphthalide on Symptomatic Atherosclerotic Stenosis in Middle Cerebral Artery | Biotech Hunter | Biotech Hunter